Friess Associates’s Adtran ADTN Stock Holding History

Friess Associates’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-201,343	Closed	-$3.71M	–	35
2022 Q1	$3.71M	Buy	+201,343	New	+$3.99M	1.98%	11

Other funds holding ADTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $209M AUM 9.57% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Friess Associates's ADTN Position: Q2 2022 in Review

Friess Associates sold out of Adtran (ADTN) in Q2 2022, closing a stake of 201,343 shares — an estimated $3.71M sold.

Friess Associates first reported a position in ADTN in Q1 2022 and held it in 1 quarter. The position peaked at $3.71M in Q1 2022. 163 funds tracked by Wall St. Rank hold ADTN as of Q2 2022.

Friess Associates reported no remaining Adtran position as of Q2 2022 after selling out during the quarter.
Friess Associates sold 201,343 Adtran shares in Q2 2022, an estimated $3.71M.
Friess Associates first reported a position in Adtran in Q1 2022 and held it in 1 quarter.
Friess Associates's Adtran position peaked at $3.71M in Q1 2022.
163 funds tracked by Wall St. Rank held Adtran as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.